Please use this identifier to cite or link to this item:
|Title:||Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy||Authors:||Gulati A.
|Keywords:||Cardiovascular magnetic resonance
Left atrial volume
|Issue Date:||2013||Publisher:||Wiley||Citation:||Gulati A., Ismail T.F., Jabbour A., Ismail N.A., Morarji K., Ali A., Raza S., Khwaja J., Brown T.D.H., Liodakis E., Baksi A.J., Shakur R., Guha K., Roughton M., Wage R., Cook S.A., Alpendurada F., Assomull R.G., Mohiaddin R.H., Cowie M.R., Pennell D.J., Prasad S.K. (2013). Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. European Journal of Heart Failure 15 (6) : 660-670. ScholarBank@NUS Repository. https://doi.org/10.1093/eurjhf/hft019||Abstract:||AimsEchocardiographic studies have shown that left atrial volume (LAV) predicts adverse outcome in small heart failure (HF) cohorts of mixed aetiology. However, the prognostic value of LAV in non-ischaemic dilated cardiomyopathy (DCM) is unknown. Cardiovascular magnetic resonance (CMR) allows accurate and reproducible measurement of LAV. We sought to determine the long-term prognostic significance of LAV assessed by CMR in DCM.Methods and resultsWe measured LAV indexed to body surface area (LAVi) in 483 consecutive DCM patients referred for CMR. Patients were prospectively followed up for a primary endpoint of all-cause mortality or cardiac transplantation. During a median follow-up of 5.3 years, 75 patients died and 9 underwent cardiac transplantation. After adjustment for established risk factors, LAVi was an independent predictor of the primary endpoint [hazard ratio (HR) per 10 mL/m2 1.08; 95% confidence interval (CI) 1.01-1.15; P = 0.022]. LAVi was also independently associated with the secondary composite endpoints of cardiovascular mortality or cardiac transplantation (HR per 10 mL/m2 1.11; 95% CI 1.04-1.19; P = 0.003), and HF death, HF hospitalization, or cardiac transplantation (HR per 10 mL/m2 1.11; 95% CI 1.04-1.18; P = 0.001). The optimal LAVi cut-off value for predicting the primary endpoint was 72 mL/m2. Patients with LAVi >72 mL/m2 had a three-fold elevated risk of death or transplantation (HR 3.00; 95% CI 1.92-4.70; P < 0.001). LAVi provided incremental prognostic value for the prediction of transplant-free survival (net reclassification improvement 0.17; 95% CI 0.05-0.29; P = 0.002).ConclusionsLAVi is a powerful independent predictor of transplant-free survival and HF outcomes in DCM. Assessment of LAV improves risk stratification in DCM and should be incorporated into routine CMR examination. All rights reserved. � 2013 The Author.||Source Title:||European Journal of Heart Failure||URI:||http://scholarbank.nus.edu.sg/handle/10635/149985||ISSN:||13889842||DOI:||10.1093/eurjhf/hft019|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 4, 2020
WEB OF SCIENCETM
checked on Jul 17, 2019
checked on Jul 3, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.